Application of 1 H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma
Veterinary and Comparative Oncology · 2025
DOI: 10.1111/vco.13034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2025. Verfasst von Rosina Sánchez Solé und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Análisis Clínicos, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, Universidad de la República, Montevideo, …. Hauptthemen laut MEDLINE: Dog Diseases, Metabolome, Lymphoma, Proton Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Programa de Desarrollo de las Ciencias Básicas, Agencia Nacional de Investigación e Innovación, Comision Academica de Posgrado, UdelaR.
Abstract (Originalsprache)
Canine lymphoma represents a biologically and metabolically heterogeneous group of neoplasms that arise from malignant transformation of lymphoid cells. An accurate diagnosis is crucial because of its impact on survival. Current diagnostic methods include clinical laboratory tests and imaging, most of which are invasive and lack sensitivity and specificity. Interestingly, recent work in cancer patients focuses on the search for biomarkers for diagnosis, investigation of treatment response mechanisms, treatment efficacy and prognosis and the discovery of tumour metabolic pathways using metabolomic analysis. In this study, we compare the metabolite profiles in serum from 37 dogs with multicentric lymphoma (22 B‐cell lymphomas/LB, 9 CD45+ T‐cell lymphomas/LTCD45+, 6 CD45‐ T‐cell lymphomas/LTCD45‐) and 25 healthy dogs using 1 H nuclear magnetic resonance spectroscopy (NMR). 1 H NMR‐based metabolite profiling analysis recognised lipids and 22 metabolites, with 16 of them altered, and was shown to be an effective approach for differentiating samples from dogs with lymphoma and healthy controls based on principal component analysis of the NMR data. We also investigated variations in the serum metabolome between immunophenotypes and the control group through pairwise comparisons of the healthy against the LB, LTCD45+ and LTCD45‐ groups, respectively which showed similar metabolomic profiles. In addition, there were significant differences in the levels of five individual metabolites based on the univariate statistical analysis. Our results showed alterations in energy, protein and lipid metabolism, suggesting glucose, lactate, N‐ acetyl glycoproteins (NAGs), scyllo‐inositol and choline as possible new candidate biomarkers in canine multicentric lymphoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Análisis Clínicos, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, Universidad de la República, Montevideo, Uruguay.
- Laboratorio de Fisicoquímica Orgánica, Departamento de Química del Litoral, CENUR Litoral Norte, Universidad de la República, Paysandú, Uruguay.
- Unidad de Reactivos y Biomodelos de Experimentación, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
ORCID-Profile: Rosina Sánchez Solé, Guillermo Moyna
Förderung
- Programa de Desarrollo de las Ciencias Básicas
- Agencia Nacional de Investigación e Innovación
- Comision Academica de Posgrado, UdelaR
Zitieren
APA
Solé, R. S., Radcenco, A. L., Moyna, G., Breijo, M., & Pessina, P. (2025). Application of 1 H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.13034
Vancouver
Solé RS, Radcenco AL, Moyna G, Breijo M, Pessina P. Application of 1 H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma. Veterinary and Comparative Oncology. 2025. doi:10.1111/vco.13034
BibTeX
@article{Sol2025,
author = {Solé, Rosina Sánchez and Radcenco, Andrés López and Moyna, Guillermo and Breijo, Martín and Pessina, Paula},
title = {Application of 1 H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma},
journal = {Veterinary and Comparative Oncology},
year = {2025},
doi = {10.1111/vco.13034}
}
EUVIMED